In a recent @ASCO podcast, Dr. @ramsedhom discussed how #PrecisionPalliativeCare should mirror the logic and the philosophy of #PrecisionOncology.

A phase-2 trial of #durvalumab used with two different meds found that both combos extended the amount of time #NSCLC patients lived without cancer growth vs. durvalumab alone, but the difference was not significant for either combo. @CharuAggarwalMD

What do you want to know?.

In a guest essay, @LGHealth's Kenneth W. Lin, MD, MPH, detailed how the availability of multicancer early detection tests is currently outpacing the evidence for their utility. @Medscape

Testing for variants in two genes before starting chemotherapy can significantly improve patient safety by providing physicians with information to help tailor doses, according to new research led by Sony Tuteja, PharmD.

“All men with #ProstateCancer should be getting next-generation sequencing,” said @KMaxwellLab, whose recent study found that Black men had higher odds of alterations in immunotherapy targets. @HemOncToday @BasserBRCA

Robert Schwab, MD, recently joined @ProgressPotent1 to discuss how #CellularImmunotherapy can be applied to #CardiovascularDisease. #CARTCellTherapy #CVD

The nonprofit MBCure has partnered with Abramson Cancer Center, @FoxChaseCancer, and @MSKCancerCenter to launch the MBCure Research Consortium, focused on #MetastaticBreastCancer research. @HC_Finance.

.@PennMedicine was part of the #BreastCancer care team for @PennState volleyball coach Katie Schumacher-Cawley. Schumacher-Cawley recently received @TheVFoundation's Jimmy V Award for Perseverance at the 2025 ESPY Awards.

Ringing the cancer bell in the infusion suite can trigger sad or painful emotions for patients whose cancer has recurred. Staff at Penn helped design a mural, “The Wall of Hope,” to create a more private space to feature the bell. @PsychToday

Studies have shown that early intervention with FDA-approved #SmokingCessation treatments—offering them before patients are willing to set a quit date—can boost the odds of eventual cessation success, said our own Frank Leone, MD. @IMMattersACP

A Penn-led study found a low rate of secondary cancers among patients who received #CARTCellTherapy. Frederic Bushman, PhD, said, “The evidence continues to reassure us that the benefits of CAR T cell therapy far outweigh the risks." @oncologynursing.

Penn researchers analyzed data from >1,000 #BreastCancer patients & found that those whose cancer was found on a screening #mammogram had a higher 5-year survival rate than those whose cancer was found after symptoms brought them to a doctor. @Dx_imaging

.@DispatchBio, a startup focused on developing a new, universal approach to treating any cancer using #immunotherapy, has announced its official launch. Our own @carlhjune is one of the company’s scientific co-founders, and @Penn is an investor. @statnews

Throwback to the big unveiling of our new mobile #mammogram van last month! A few days later, we hit the road for our very first screening event in #WestPhilly. We're excited to bring lifesaving #BreastCancer screenings to more communities across the region.

Our own Stefan Barta, MD, discussed the evolving landscape of immunotherapies for T-cell lymphomas. “Targeting the [T-cell lymphoma] with T cells can be much more difficult than it is in other cancers,” like the more common B-cell lymphomas." @TargetedOnc

After isolating a new class of molecules from Aspergillus flavus, @PennEngineers researchers modified the chemicals and tested them against leukemia cells. The result? A promising cancer-killing compound.

Watch the short film here:

"When you save one life, it's as if you've saved the entire world," said @BLLPHD. Levine, who helped develop #CARTCellTherapy, recently shared his story with "tell us", a creative film agency dedicated to storytelling that inspires and creates real impact.

A study found chemoradiation + immunotherapy aided survival outcomes in resectable #BileDuctCancer. Edgar Ben-Josef, MD, noted that while the post-surgery combo therapy was shown to be an active regimen, the study left unanswered questions. @medpagetoday

Beth Sandy, MSN, CRNP, joined the @oncologynursing Podcast to discuss #LungCancer #survivorship. “These patients are living longer. Our treatments are better. And so no matter who they are, they have every chance of surviving long term for this.”